Stifel Financial’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.01M | Sell |
11,456
-6
| -0.1% | -$528 | ﹤0.01% | 2324 |
|
|
2025
Q1 | $1.04M | Buy |
11,462
+61
| +0.5% | +$5.56K | ﹤0.01% | 2196 |
|
|
2024
Q4 | $984K | Buy |
11,401
+3,591
| +46% | +$310K | ﹤0.01% | 2253 |
|
|
2024
Q3 | $742K | Buy |
7,810
+924
| +13% | +$87.8K | ﹤0.01% | 2420 |
|
|
2024
Q2 | $630K | Buy |
6,886
+36
| +0.5% | +$3.29K | ﹤0.01% | 2468 |
|
|
2024
Q1 | $621K | Sell |
6,850
-6,635
| -49% | -$602K | ﹤0.01% | 2480 |
|
|
2023
Q4 | $1.1M | Buy |
13,485
+2,735
| +25% | +$223K | ﹤0.01% | 2085 |
|
|
2023
Q3 | $859K | Sell |
10,750
-669
| -6% | -$53.4K | ﹤0.01% | 2145 |
|
|
2023
Q2 | $899K | Sell |
11,419
-287
| -2% | -$22.6K | ﹤0.01% | 2150 |
|
|
2023
Q1 | $909K | Sell |
11,706
-4,160
| -26% | -$323K | ﹤0.01% | 2123 |
|
|
2022
Q4 | $1.23M | Sell |
15,866
-15,488
| -49% | -$1.2M | ﹤0.01% | 1845 |
|
|
2022
Q3 | $2.11M | Buy |
31,354
+36
| +0.1% | +$2.42K | ﹤0.01% | 1429 |
|
|
2022
Q2 | $2.41M | Buy |
31,318
+23,695
| +311% | +$1.82M | ﹤0.01% | 1382 |
|
|
2022
Q1 | $608K | Hold |
7,623
| – | – | ﹤0.01% | 2465 |
|
|
2021
Q4 | $587K | Hold |
7,623
| – | – | ﹤0.01% | 2507 |
|
|
2021
Q3 | $555K | Hold |
7,623
| – | – | ﹤0.01% | 2521 |
|
|
2021
Q2 | $557K | Sell |
7,623
-573
| -7% | -$41.9K | ﹤0.01% | 2522 |
|
|
2021
Q1 | $566K | Sell |
8,196
-3,729
| -31% | -$258K | ﹤0.01% | 2401 |
|
|
2020
Q4 | $793K | Buy |
+11,925
| New | +$793K | ﹤0.01% | 2021 |
|